Tricyclic 2′-C-Modified Nucleosides as Potential Anti-HCV Therapeutics

被引:19
作者
Wauchope, Orrette R. [2 ]
Tomney, Matthew J. [2 ]
Pepper, Joseph L. [2 ]
Korba, Brent E. [1 ]
Seley-Radtke, Katherine L. [1 ]
机构
[1] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20057 USA
[2] Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA
关键词
C VIRUS-REPLICATION; INHIBITORS; DESIGN;
D O I
10.1021/ol101482h
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Promising biological activity in a number of therapeutic areas has been reported for both tricyclic nucleosides and 2'-modified nucleosides. In particular, disubstitution at the C-2' position of nucleosides has resulted in significant activity against the hepatitis C virus (HCV). Combining this with the observation that tricyclic nucleosides developed in our laboratory have been shown to inhibit the RNA-dependent RNA polymerase NS5B led to the design of a series of 2'-modified tricyclic nucleosides. Details of the synthesis, structural characterization, and preliminary biological results are reported.
引用
收藏
页码:4466 / 4469
页数:4
相关论文
共 40 条
  • [21] siRNA Modified with 2-Deoxy-2-C-methylpyrimidine Nucleosides
    Dellafiore, Maria
    Avino, Anna
    Alagia, Adele
    Montserrat, Javier M.
    Iribarren, Adolfo M.
    Eritja, Ramon
    [J]. CHEMBIOCHEM, 2018, 19 (13) : 1409 - 1413
  • [22] Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine
    Tan, Rebecca Shu Ling
    Hassandarvish, Pouya
    Chee, Chin Fei
    Chan, Lai Wah
    Wong, Tin Wui
    [J]. CARBOHYDRATE POLYMERS, 2022, 290
  • [23] Synthesis of 2′-β-C-methyl toyocamycin and sangivamycin analogues as potential HCV inhibitors
    Ding, YL
    An, HY
    Hong, Z
    Girardet, JL
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 725 - 727
  • [24] Synthesis and Anti-HCV Activities of 4′-Fluoro-2′-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4′-Fluoro-2′-C-methyluridine 5′-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection
    Wang, Guangyi
    Dyatkina, Natalia
    Prhavc, Marija
    Williams, Caroline
    Serebryany, Vladimir
    Hu, Yujian
    Huang, Yongfei
    Wan, Jinqiao
    Wu, Xiangyang
    Deval, Jerome
    Fung, Amy
    Jin, Zhinan
    Fan, Hua
    Shaw, Kenneth
    Kang, Hyunsoon
    Zhang, Qingling
    Tam, Yuen
    Stoycheva, Antitsa
    Jekle, Andreas
    Smith, David B.
    Beigelman, Leonid
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (09) : 4555 - 4570
  • [25] Computational Screening of Neuropilin-1 Unveils Novel Potential Anti-SARS-CoV-2 Therapeutics
    Afiadenyo, Michael
    Adams, Latif
    Agoni, Clement
    Moane, Siobhan
    Mckeon-Bennett, Michelle
    Obiri-Yeboah, Dorcas
    Singh, Jasdeep
    [J]. CHEMISTRY & BIODIVERSITY, 2023, 20 (12)
  • [26] Syntheses of nucleosides with 2′-spirolactam and 2′-spiropyrrolidine moieties as potential inhibitors of hepatitis C virus NS5B polymerase
    Dang, Qun
    Zhang, Zhibo
    Tang, Bingyu
    Song, Yang
    Wu, Ling
    Chen, Tongqian
    Bogen, Stephane
    Girijavallabhan, Vinay
    Olsen, David B.
    Meinke, Peter T.
    [J]. TETRAHEDRON LETTERS, 2014, 55 (28) : 3813 - 3816
  • [27] Discovery of a 2′-α-Fluoro-2′-β-C-(fluoromethyl) Purine Nucleotide Prodrug as a Potential Oral Anti-SARS-CoV-2 Agent
    Liang, Lan
    Meng, Yonggang
    Chang, Xiaoyu
    Li, Ertong
    Huang, Yucen
    Yan, Liming
    Lou, Zhiyong
    Peng, Youmei
    Zhu, Bo
    Yu, Wenquan
    Chang, Junbiao
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 1994 - 2007
  • [28] Syntheses of nucleosides with a 1′,2′-β-lactam moiety as potential inhibitors of hepatitis C virus NS5B polymerase
    Dang, Qun
    Zhang, Zhibo
    Bai, Yunfeng
    Sun, Ruijun
    Yin, Jie
    Chen, Tongqian
    Bogen, Stephane
    Girijavallabhan, Vinay
    Olsen, David B.
    Meinke, Peter T.
    [J]. TETRAHEDRON LETTERS, 2014, 55 (40) : 5576 - 5579
  • [29] Synthesis and anti-HCV activity of novel 5-arylmethylene-1,3-thiazolidi-n-4-one derivatives via suppression of NS5B polymerase and COX-2
    Kulabas, Necla
    Lee, Jin-Ching
    Ozakpinar, Ozlem Bingol
    Kucukguzel, Ilkay
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 2024, 1311
  • [30] Synthesis and biological evaluation of novel anti-hepatitis C virus (HCV) agents: 2-hydroxylphenethyl sulfanyl-oxopyrimidines
    Wu, Daochun
    Feng, Yue
    Wang, Hua
    Yang, Junfeng
    Chen, Xian
    Wang, Yueping
    Lai, Christopher Cong
    Zhang, Yufang
    Li, Cong
    Xia, Xueshan
    He, Yanping
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2017, 26 (07) : 1388 - 1396